BMY Financial Facts

Research and development: 1.14B
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
See Full Income Statement

U.S. and foreign income taxes payable: 312M
Total Equity: 15.78B
See Full Balance Sheet

Bristol-Myers Squibb Company (BMY) Earnings

  |   Expand Research on BMY
Next EPS Date 8/6/21 *Est. EPS Growth Rate +1.2% *Last Qtr.
Average EPS % Beat Rate +4.8% Revenue Growth Rate +2.8% *Last Qtr.
Average % Move 1-Wk after EPS -2.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/29/21 Q121 $1.74$1.81 -$0.07$11.1B$11.11B = Details
2/4/21 Q420 $1.46$1.41 +$0.05$11.07B$10.73B = Details
11/5/20 Q320 $1.63$1.49 +$0.14$10.5B$10.33B = Details
8/6/20 Q220 $1.63$1.48 +$0.15$10.1B$9.97B = Details
5/7/20 Q120 $1.72$1.49 +$0.23$10.8B$10.02B = Details
2/6/20 Q419 $1.22$0.94 +$0.28$7.9B$6.19B = Details
10/31/19 Q319 $1.17$1.07 +$0.10$6.01B$5.89B = Details
7/25/19 Q219 $1.18$1.06 +$0.12$6.3B$6.11B Details